329 related articles for article (PubMed ID: 12341188)
1. Depo-Provera use in Sri Lanka: acceptor characteristics, continuation and side effects.
Basnayake S; Thapa S
Adv Contracept Deliv Syst; 1986 Oct; 2(4):307-21. PubMed ID: 12341188
[TBL] [Abstract][Full Text] [Related]
2. Use of a long-acting injectable contraceptive in a postpartum family planning program.
Mcdaniel EB; Pardthaisong T
Asian J Med; 1973 Apr; 9(4):133-5. PubMed ID: 12262537
[TBL] [Abstract][Full Text] [Related]
3. Depo-provera: clinical evaluation.
Mukherjea M
Contracept Deliv Syst; 1981 Jul; 2(3):259-69. PubMed ID: 12278913
[TBL] [Abstract][Full Text] [Related]
4. Acceptability study of the two versus three monthly injectable contraceptives.
Aly FA; El-genedi MM; Toppozada HK; El-abd M; Loutfi I
Dirasat Sukkaniyah; 1984; 11(69):27-39. PubMed ID: 12179796
[TBL] [Abstract][Full Text] [Related]
5. Depo-Provera highly effective as injectable contraceptive.
Denniston GC
Contracept Technol Update; 1985 Dec; 6(12):167-8. PubMed ID: 12280301
[TBL] [Abstract][Full Text] [Related]
6. Continuation of injectable contraceptives in Thailand.
Narkavonnakit T; Bennett T; Balakrishnan TR
Stud Fam Plann; 1982 Apr; 13(4):99-105. PubMed ID: 6216633
[TBL] [Abstract][Full Text] [Related]
7. A comparison of levonorgestrel implants with depo-medroxyprogesterone acetate injections for contraception.
London RS
J SOGC; 1993 Oct; 15(8):925-8, 32. PubMed ID: 12318530
[TBL] [Abstract][Full Text] [Related]
8. Long-term depot medroxyprogesterone acetate (Depo-Provera) use in inner-city adolescents.
Polaneczky M; Liblanc M
J Adolesc Health; 1998 Aug; 23(2):81-8. PubMed ID: 9714170
[TBL] [Abstract][Full Text] [Related]
9. Ask the experts: progestin-only contraceptives.
Hatcher RA; Schnare S
Contracept Technol Update; 1993 Jul; 14(7):114-5. PubMed ID: 12286999
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and acceptability of depo-medroxyprogesterone acetate injection. As a method of contraception in Saudi Arabia.
Sobande AA; Al-Bar HM; Archibong EI; Sadek AA
Saudi Med J; 2000 Apr; 21(4):348-51. PubMed ID: 11533816
[TBL] [Abstract][Full Text] [Related]
11. Depo Provera: still controversial.
Wren LM
Int Health News; 1988 Feb; 9(2):2-3, 8. PubMed ID: 12179873
[TBL] [Abstract][Full Text] [Related]
12. The use of depot medroxyprogesterone acetate (DMPA) injectable contraceptive in Enugu, Nigeria.
Hu E; Ikeako LC; Obiora-Okafor NC
Niger J Med; 2012; 21(3):266-71. PubMed ID: 23304918
[TBL] [Abstract][Full Text] [Related]
13. First Asian Workshop on Injectable Contraceptives.
IPPF Med Bull; 1978 Jun; 12(3):3. PubMed ID: 12309036
[TBL] [Abstract][Full Text] [Related]
14. Depo-Provera use in an Australian metropolitan practice.
Fraser IS; Dennerstein GJ
Med J Aust; 1994 May; 160(9):553-6. PubMed ID: 8164553
[TBL] [Abstract][Full Text] [Related]
15. Extracts from the report on the Joint IGCC/IFRP East and South East Asia Seminar on Regional Fertility Research.
Mcdaniel EB
IGCC News; 1980 Jan; 5(3):1-4. PubMed ID: 12179403
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment counseling keeps patients on Depo.
Contracept Technol Update; 1997 Oct; 18(10):125-6. PubMed ID: 12321212
[TBL] [Abstract][Full Text] [Related]
17. [Prolonged use of medroxyprogesterone acetate for contraception].
Pena Delgado J; Aleman Herrera M; Baez Reyes A
Sem Med Mex; 1981 Jun; 98(11):331-50. PubMed ID: 12279435
[TBL] [Abstract][Full Text] [Related]
18. Cyclofem shoots into injectable market.
Family Plan World; 1992; ():19. PubMed ID: 12290896
[TBL] [Abstract][Full Text] [Related]
19. Depo-Provera -- proving its innocence.
Choudhury IR
Indian Med Trib; 1994 Jul; 2(11):5. PubMed ID: 12179187
[TBL] [Abstract][Full Text] [Related]
20. Three-monthly Depo-Provera in Mexico.
Correu Azcona S
IPPF Med Bull; 1977 Jun; 11(3):2-3. PubMed ID: 12335212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
